BlackRock, Inc.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 2012383 New York, NY

Position in SUPN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$454,730,052

+$20,557,420 QoQ

Shares Held

8,797,254

+0.7% QoQ

Ownership

15.2%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 97.99963715950454.ToString("F0")% Shared 0.ToString("F0")% None 2.0003628404954545.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $19,745,764,999 across 67 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	35,584,312	$4,206,421,510
2	UTHR	UNITED THERAPEUTICS Corp	5,399,649	$3,201,883,855
3	TEVA	Teva Pharmaceutical Industries Ltd	65,136,464	$1,961,910,288
4	NBIX	Neurocrine Biosciences Inc	13,385,607	$1,763,419,854
5	VTRS	Viatris Inc	84,359,804	$1,139,700,941
6	ELAN	Elanco Animal Health Inc	47,622,630	$1,139,609,527
7	ALKS	Alkermes plc.	28,314,410	$1,001,197,527
8	LNTH	Lantheus Holdings, Inc.	8,183,193	$620,695,182

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$454,730,052	8,797,254	+0.7%	Shares	Sole	2026-05-13
2025-12-31	$434,172,632	8,735,868	+0.4%	Shares	Sole	2026-02-12
2025-09-30	$415,697,005	8,698,410	-7.1%	Shares	Sole	2025-11-12
2025-06-30	$295,276,008	9,367,894	-3.3%	Shares	Sole	2025-08-12
2025-03-31	$317,169,071	9,684,552	-3.1%	Shares	Sole	2025-05-02
2024-12-31	$361,525,358	9,997,936	-0.7%	Shares	Sole	2025-02-07
2024-09-30	$313,886,932	10,066,932	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.